Production (Stage)
PureTech Health plc
PRTC
$18.20
-$0.80-4.21%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 181.45% | 74.31% | -75.41% | -52.17% | -30.47% |
Total Depreciation and Amortization | -27.61% | -42.37% | -51.88% | -47.93% | -44.53% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -189.15% | -16.02% | 68.47% | 63.38% | 59.10% |
Change in Net Operating Assets | -158.43% | -141.10% | -113.76% | -40.82% | 10.05% |
Cash from Operations | -26.86% | 2.83% | 22.90% | 32.42% | 40.76% |
Capital Expenditure | 84.29% | 98.36% | 100.00% | 97.48% | 96.78% |
Sale of Property, Plant, and Equipment | -70.52% | -50.65% | -21.53% | 125.08% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -564.32% | -232.16% | 100.00% | 3.36% | -2,777.66% |
Other Investing Activities | 305.24% | 173.67% | 50.17% | 1,337.07% | 178.40% |
Cash from Investing | 249.16% | 161.34% | 78.96% | 695.69% | 164.34% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -1.68% | 9.78% | 19.35% | 18.20% | 17.07% |
Issuance of Common Stock | -22.38% | -18.74% | -15.47% | 38.44% | 247.29% |
Repurchase of Common Stock | -447.37% | -360.58% | -302.77% | -147.30% | 25.83% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -6.88% | -19.37% | -31.86% | 68.23% | 285,745.71% |
Cash from Financing | -121.70% | -147.86% | -178.03% | -33.30% | 361.98% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 117.30% | 84.05% | -173.06% | 99.75% | 113.05% |